Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure

Recruiting

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(23 sites)

United States

Research Site, Charlotte, North Carolina

Research Site, Columbus, Ohio

Research Site, Philadelphia, Pennsylvania

Czechia

Research Site, Brno

Research Site, Hradec Králové

Research Site, Prague

Italy

Research Site, Cagliari

Research Site, Florence

Research Site, Milan

Research Site, Pavia

Research Site, Perugia

Poland

Research Site, Krakow

Research Site, Poznan

Spain

Research Site, Barcelona

Research Site, Madrid

Research Site, Seville

United Kingdom

Research Site, Bournemouth

Research Site, Oxford

Research Site, Plymouth

Research Site, Romford

Research Site, Stockton

Research Site, Sutton Coldfield